• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Author's Reply to Freund and Gorlicki: "Door-to-Diuretic Time and Outcomes in Acute Heart Failure: A Scoping Review".

作者信息

Oduah Mary Tiffany, Ilonze Onyedika J

机构信息

Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA.

Division of Cardiovascular Medicine, Krannert Cardiovascular Research Center, Indiana University School of Medicine, 1801 N Senate Ave Suite 2000, Indianapolis, IN, 46202, USA.

出版信息

Am J Cardiovasc Drugs. 2025 Apr 1. doi: 10.1007/s40256-025-00730-3.

DOI:10.1007/s40256-025-00730-3
PMID:40167902
Abstract
摘要

相似文献

1
Author's Reply to Freund and Gorlicki: "Door-to-Diuretic Time and Outcomes in Acute Heart Failure: A Scoping Review".作者对弗罗因德和戈利茨基的回复：“急性心力衰竭的门到利尿剂给药时间及预后：一项范围综述”
Am J Cardiovasc Drugs. 2025 Apr 1. doi: 10.1007/s40256-025-00730-3.
2
Door-to-Diuretic Time and Outcomes in Acute Heart Failure: A Scoping Review.急性心力衰竭中从就诊到使用利尿剂的时间与结局：一项范围综述
Am J Cardiovasc Drugs. 2025 May;25(3):349-359. doi: 10.1007/s40256-024-00704-x. Epub 2024 Dec 15.
3
Comment on: "Door-to-Diuretic Time and Outcomes in Acute Heart Failure: A Scoping Review".对《急性心力衰竭的门到利尿剂使用时间及结局：一项范围综述》的评论
Am J Cardiovasc Drugs. 2025 Apr 1. doi: 10.1007/s40256-025-00729-w.
4
Ultrafiltration for acute decompensated cardiac failure: A systematic review and meta-analysis.急性失代偿性心力衰竭的超滤治疗：一项系统评价与荟萃分析。
Int J Cardiol. 2017 Feb 1;228:122-128. doi: 10.1016/j.ijcard.2016.11.136. Epub 2016 Nov 9.
5
Hemoglobin to red cell distribution width ratio: A predictor of clinical outcome and diuretic response in patients with acute heart failure.血红蛋白与红细胞分布宽度比值：急性心力衰竭患者临床结局和利尿剂反应的预测指标。
Int J Cardiol. 2024 Jan 1;394:131368. doi: 10.1016/j.ijcard.2023.131368. Epub 2023 Sep 20.
6
Flexible diuretic titration in chronic heart failure: where is the evidence?慢性心力衰竭中利尿剂的弹性滴定：有何证据？
J Card Fail. 2011 Nov;17(11):944-54. doi: 10.1016/j.cardfail.2011.10.001.
7
Racial differences in diuretic therapy, B-type natriuretic peptide values, and prognosis in acute heart failure.急性心力衰竭中利尿剂治疗、B型利钠肽值及预后的种族差异
J Cardiol. 2025 Jun;85(6):486-493. doi: 10.1016/j.jjcc.2025.01.013. Epub 2025 Jan 30.
8
Admission Ca-125 to identify diuretic response in hospitalized patients with acute decompensated heart failure.入院时检测癌抗原125以识别急性失代偿性心力衰竭住院患者的利尿反应。
Heart Lung. 2025 Jul 2;74:90-95. doi: 10.1016/j.hrtlng.2025.06.012.
9
On-treatment analysis of torsemide versus furosemide for patients hospitalized for heart failure: A post-hoc analysis of TRANSFORM-HF.治疗分析：托塞米对比呋塞米治疗心力衰竭住院患者：TRANSFORM-HF 的事后分析。
Eur J Heart Fail. 2024 Jul;26(7):1518-1523. doi: 10.1002/ejhf.3293. Epub 2024 May 15.
10
Natriuretic response prediction equation for use with oral diuretics in heart failure.用于心力衰竭患者口服利尿剂的利钠反应预测方程。
Eur Heart J. 2025 Jul 1;46(25):2410-2418. doi: 10.1093/eurheartj/ehaf268.

本文引用的文献

1
Door-to-Diuretic Time and Outcomes in Acute Heart Failure: A Scoping Review.急性心力衰竭中从就诊到使用利尿剂的时间与结局：一项范围综述
Am J Cardiovasc Drugs. 2025 May;25(3):349-359. doi: 10.1007/s40256-024-00704-x. Epub 2024 Dec 15.
2
Avoiding Treatment in Hospital With Subcutaneous Furosemide for Worsening Heart Failure: A Pilot Study (AT HOME-HF).避免使用皮下呋塞米治疗心力衰竭恶化：一项试点研究（AT HOME-HF）。
JACC Heart Fail. 2024 Nov;12(11):1830-1841. doi: 10.1016/j.jchf.2024.07.015. Epub 2024 Sep 11.
3
Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial.
升阶梯治疗急性心力衰竭指南导向的药物治疗的安全性、耐受性和疗效（STRONG-HF）：一项多中心、开放标签、随机试验。
Lancet. 2022 Dec 3;400(10367):1938-1952. doi: 10.1016/S0140-6736(22)02076-1. Epub 2022 Nov 7.
4
Prevalence, predictors and clinical outcome of residual congestion in acute decompensated heart failure.急性失代偿性心力衰竭患者中残余充血的患病率、预测因素和临床结局。
Int J Cardiol. 2018 May 1;258:185-191. doi: 10.1016/j.ijcard.2018.01.067.
5
Worsening Renal Function in Patients With Acute Heart Failure Undergoing Aggressive Diuresis Is Not Associated With Tubular Injury.在接受积极利尿治疗的急性心力衰竭患者中，肾功能恶化与肾小管损伤无关。
Circulation. 2018 May 8;137(19):2016-2028. doi: 10.1161/CIRCULATIONAHA.117.030112. Epub 2018 Jan 19.
6
Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group.控释美托洛尔对心力衰竭患者总死亡率、住院率及健康状况的影响：美托洛尔控释/缓释片在充血性心力衰竭中的随机干预试验（MERIT-HF）。MERIT-HF研究组
JAMA. 2000 Mar 8;283(10):1295-302. doi: 10.1001/jama.283.10.1295.